DALLAH HEALTH

Dallah Healthcare Co.

4004StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operations
Operating Cash Flow	555.39M	678.29M	625.78M	442.13M	361.55M
Free Cash Flow	90.10M	314.65M	331.28M	269.44M	245.93M
Capital Expenditures	-465.29M	-363.64M	-294.51M	-172.69M	-115.62M
Investing & Financing
Investing Cash Flow	-787.39M	-357.15M	-293.68M	-179.12M	-425.30M
Financing Cash Flow	276.24M	-390.12M	-334.74M	-233.15M	141.19M
Dividends Paid	-202.38M	-195.01M	-146.52M	-180.00M	-162.50M
Share Repurchase	-13.57M	-60.46M	—	—	—
Operating Activities
Operating Cash Flow	555.39M	678.29M	625.78M	442.13M	361.55M
Net Income	538.27M	471.20M	360.12M	274.46M	258.60M
Change in Accounts Payable	-16.71M	55.23M	7.78M	25.94M	29.25M
Change in Accounts Receivable	-266.54M	-80.52M	-76.35M	-57.92M	-70.18M
Change in Inventory	-68.12M	-34.36M	30.46M	-38.69M	-52.21M
Change in Other Net Operating Assets	25.14M	1.14M	-4.87M	-46.79M	-35.29M
Change in Working Capital	-326.23M	-58.51M	-42.98M	-117.47M	-128.43M
Other Operating Activities	120.30M	137.63M	151.80M	143.08M	68.27M
Provision & Write-off of Bad Debts	49.63M	30.40M	29.26M	6.05M	17.10M
Depreciation & Amortization	220.13M	140.07M	124.35M	114.15M	115.11M
Other Amortization	4.55M	0.42M	1.26M	0.11M	—
Cash Interest Paid	173.44M	95.64M	—	54.88M	35.76M
Loss (Gain) on Equity Investments	-51.70M	-42.97M	1.86M	22.82M	31.08M
Investing Activities
Investing Cash Flow	-787.39M	-357.15M	-293.68M	-179.12M	-425.30M
Capital Expenditures	-465.29M	-363.64M	-294.51M	-172.69M	-115.62M
Cash Acquisitions	-313.82M	—	—	-9.45M	—
Investment in Securities	-8.70M	—	—	-0.28M	-313.81M
Other Investing Activities	3.92M	8.17M	1.71M	3.93M	3.86M
Sale (Purchase) of Intangibles	-4.26M	-1.67M	-2.15M	-2.30M	-0.07M
Sale of Property, Plant & Equipment	0.75M	0.00M	1.26M	1.68M	0.34M
Loss (Gain) From Sale of Assets	0.43M	0.05M	0.10M	-1.07M	-0.19M
Loss (Gain) on Sale of Investments	—	—	—	—	—
Financing Activities
Financing Cash Flow	276.24M	-390.12M	-334.74M	-233.15M	141.19M
Common Dividends Paid	-202.38M	-195.01M	-146.52M	-180.00M	-162.50M
Repurchase of Common Stock	-13.57M	-60.46M	—	—	—
Long-Term Debt Issued	2.42B	0.72B	0.23B	0.72B	0.73B
Total Debt Issued	2.42B	0.72B	0.23B	0.72B	0.73B
Long-Term Debt Repaid	-1.31B	-0.75B	-0.30B	-0.68B	-0.39B
Total Debt Repaid	-1.31B	-0.75B	-0.30B	-0.68B	-0.39B
Net Debt Issued (Repaid)	1.11B	-0.03B	-0.06B	0.05B	0.34B
Other Financing Activities	-615.57M	-102.41M	-125.21M	-101.89M	-32.25M
Free Cash Flow & Returns
Free Cash Flow	90.10M	314.65M	331.28M	269.44M	245.93M
Free Cash Flow Growth	-71.4%	-5.0%	+23.0%	+9.6%	+356.0%
Free Cash Flow Margin	+2.2%	+9.8%	+11.3%	+10.8%	+11.7%
Free Cash Flow Per Share	0.89	3.23	3.40	2.99	2.73
Levered Free Cash Flow	-220.16M	-137.56M	110.12M	110.49M	94.56M
Unlevered Free Cash Flow	-127.91M	-70.88M	175.21M	154.55M	117.37M
Operating Cash Flow Growth	-18.1%	+8.4%	+41.5%	+22.3%	+97.2%
Net Cash Flow	44.24M	-68.98M	-2.64M	29.87M	77.43M

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operations
Operating Cash Flow	555.39M	678.29M	625.78M	442.13M	361.55M
Free Cash Flow	90.10M	314.65M	331.28M	269.44M	245.93M
Capital Expenditures	-465.29M	-363.64M	-294.51M	-172.69M	-115.62M
Investing & Financing
Investing Cash Flow	-787.39M	-357.15M	-293.68M	-179.12M	-425.30M
Financing Cash Flow	276.24M	-390.12M	-334.74M	-233.15M	141.19M
Dividends Paid	-202.38M	-195.01M	-146.52M	-180.00M	-162.50M
Share Repurchase	-13.57M	-60.46M	—	—	—
Operating Activities
Operating Cash Flow	555.39M	678.29M	625.78M	442.13M	361.55M
Net Income	538.27M	471.20M	360.12M	274.46M	258.60M
Change in Accounts Payable	-16.71M	55.23M	7.78M	25.94M	29.25M
Change in Accounts Receivable	-266.54M	-80.52M	-76.35M	-57.92M	-70.18M
Change in Inventory	-68.12M	-34.36M	30.46M	-38.69M	-52.21M
Change in Other Net Operating Assets	25.14M	1.14M	-4.87M	-46.79M	-35.29M
Change in Working Capital	-326.23M	-58.51M	-42.98M	-117.47M	-128.43M
Other Operating Activities	120.30M	137.63M	151.80M	143.08M	68.27M
Provision & Write-off of Bad Debts	49.63M	30.40M	29.26M	6.05M	17.10M
Depreciation & Amortization	220.13M	140.07M	124.35M	114.15M	115.11M
Other Amortization	4.55M	0.42M	1.26M	0.11M	—
Cash Interest Paid	173.44M	95.64M	—	54.88M	35.76M
Loss (Gain) on Equity Investments	-51.70M	-42.97M	1.86M	22.82M	31.08M
Investing Activities
Investing Cash Flow	-787.39M	-357.15M	-293.68M	-179.12M	-425.30M
Capital Expenditures	-465.29M	-363.64M	-294.51M	-172.69M	-115.62M
Cash Acquisitions	-313.82M	—	—	-9.45M	—
Investment in Securities	-8.70M	—	—	-0.28M	-313.81M
Other Investing Activities	3.92M	8.17M	1.71M	3.93M	3.86M
Sale (Purchase) of Intangibles	-4.26M	-1.67M	-2.15M	-2.30M	-0.07M
Sale of Property, Plant & Equipment	0.75M	0.00M	1.26M	1.68M	0.34M
Loss (Gain) From Sale of Assets	0.43M	0.05M	0.10M	-1.07M	-0.19M
Loss (Gain) on Sale of Investments	—	—	—	—	—
Financing Activities
Financing Cash Flow	276.24M	-390.12M	-334.74M	-233.15M	141.19M
Common Dividends Paid	-202.38M	-195.01M	-146.52M	-180.00M	-162.50M
Repurchase of Common Stock	-13.57M	-60.46M	—	—	—
Long-Term Debt Issued	2.42B	0.72B	0.23B	0.72B	0.73B
Total Debt Issued	2.42B	0.72B	0.23B	0.72B	0.73B
Long-Term Debt Repaid	-1.31B	-0.75B	-0.30B	-0.68B	-0.39B
Total Debt Repaid	-1.31B	-0.75B	-0.30B	-0.68B	-0.39B
Net Debt Issued (Repaid)	1.11B	-0.03B	-0.06B	0.05B	0.34B
Other Financing Activities	-615.57M	-102.41M	-125.21M	-101.89M	-32.25M
Free Cash Flow & Returns
Free Cash Flow	90.10M	314.65M	331.28M	269.44M	245.93M
Free Cash Flow Growth	-71.4%	-5.0%	+23.0%	+9.6%	+356.0%
Free Cash Flow Margin	+2.2%	+9.8%	+11.3%	+10.8%	+11.7%
Free Cash Flow Per Share	0.89	3.23	3.40	2.99	2.73
Levered Free Cash Flow	-220.16M	-137.56M	110.12M	110.49M	94.56M
Unlevered Free Cash Flow	-127.91M	-70.88M	175.21M	154.55M	117.37M
Operating Cash Flow Growth	-18.1%	+8.4%	+41.5%	+22.3%	+97.2%
Net Cash Flow	44.24M	-68.98M	-2.64M	29.87M	77.43M